P. Devillier

642 total citations
20 papers, 520 citations indexed

About

P. Devillier is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, P. Devillier has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in P. Devillier's work include Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Chemical Synthesis and Analysis (4 papers). P. Devillier is often cited by papers focused on Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Chemical Synthesis and Analysis (4 papers). P. Devillier collaborates with scholars based in France, Canada and Belgium. P. Devillier's co-authors include D. Regoli, J Marsac, Charles Advenier, Guy Drapeau, Emmanuel Naline, Ingo Konetzki, Thierry Bouyssou, Sabine Pestel, Paola Casarosa and A. Schnapp and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and European Respiratory Journal.

In The Last Decade

P. Devillier

17 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Devillier France 10 285 184 166 165 60 20 520
F Perretti Italy 13 275 1.0× 101 0.5× 313 1.9× 179 1.1× 28 0.5× 25 530
Adrian N. Payne United Kingdom 15 336 1.2× 168 0.9× 59 0.4× 130 0.8× 44 0.7× 23 523
M.G. McKenniff United Kingdom 7 273 1.0× 154 0.8× 66 0.4× 88 0.5× 46 0.8× 9 357
Sergio Parra United States 12 285 1.0× 169 0.9× 151 0.9× 318 1.9× 22 0.4× 35 609
Karmelo M. Lulich Australia 8 250 0.9× 164 0.9× 74 0.4× 102 0.6× 25 0.4× 15 360
Marilyn Grous United States 12 264 0.9× 95 0.5× 93 0.6× 433 2.6× 23 0.4× 22 681
Blanca Bazán‐Perkins Mexico 13 127 0.4× 68 0.4× 57 0.3× 121 0.7× 48 0.8× 41 403
Masayuki Endou Japan 14 124 0.4× 31 0.2× 140 0.8× 329 2.0× 23 0.4× 33 546
Anne Floch France 11 162 0.6× 59 0.3× 90 0.5× 167 1.0× 5 0.1× 13 392
Faiq J. Al-Bazzaz United States 14 203 0.7× 319 1.7× 108 0.7× 292 1.8× 5 0.1× 26 664

Countries citing papers authored by P. Devillier

Since Specialization
Citations

This map shows the geographic impact of P. Devillier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Devillier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Devillier more than expected).

Fields of papers citing papers by P. Devillier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Devillier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Devillier. The network helps show where P. Devillier may publish in the future.

Co-authorship network of co-authors of P. Devillier

This figure shows the co-authorship network connecting the top 25 collaborators of P. Devillier. A scholar is included among the top collaborators of P. Devillier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Devillier. P. Devillier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Salvator, Hélène, Stanislas Grassin‐Delyle, Charlotte Abrial, et al.. (2019). Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists. A4540–A4540. 3 indexed citations
4.
Gilet, Hélène, Christophe Pignier, B. Aguilaniu, et al.. (2015). Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire. Value in Health. 18(7). A712–A712. 3 indexed citations
5.
Grassin‐Delyle, Stanislas, Emmanuel Naline, Amparo Buenestado, et al.. (2014). Cannabinoids inhibit cholinergic contraction in human airways through prejunctionalCB1receptors. British Journal of Pharmacology. 171(11). 2767–2777. 37 indexed citations
7.
Gilet, Hélène, B. Aguilaniu, Benoît Arnould, et al.. (2014). Évaluation multidimensionnelle de la dyspnée au cours de la BPCO : étude observationnelle prospective. Revue des Maladies Respiratoires. 32. A91–A91. 1 indexed citations
8.
Devillier, P., et al.. (2014). Implication de la voie des kynurénines dans la polarisation des macrophages pulmonaires humains. Revue des Maladies Respiratoires. 31(9). 879–879. 1 indexed citations
9.
Roche, Nicolás, Roger Marthan, Patrick Berger, et al.. (2011). Beyond corticosteroids: future prospects in the management of inflammation in COPD. European Respiratory Review. 20(121). 175–182. 32 indexed citations
10.
Roche, Nicolás, P. Devillier, B. Aguilaniu, et al.. (2011). BPCO et inflammation : mise au point d’un groupe d’experts. Comment traiter l’inflammation ?. Revue des Maladies Respiratoires. 28(4). 427–442. 2 indexed citations
11.
Bouyssou, Thierry, Paola Casarosa, Emmanuel Naline, et al.. (2010). Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models. Journal of Pharmacology and Experimental Therapeutics. 334(1). 53–62. 98 indexed citations
12.
Marchac, Valentine, et al.. (2007). Propionate de fluticasone dans l'asthme de l'enfant et du nourrisson. Archives de Pédiatrie. 14(4). 376–387. 3 indexed citations
13.
Devillier, P., G Acker, Charles Advenier, et al.. (1992). Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.. Journal of Pharmacology and Experimental Therapeutics. 263(2). 767–772. 45 indexed citations
14.
Devillier, P., Luz Candenas, Emmanuel Naline, & Charles Advenier. (1992). Influence of benzodiazepines on the response of the guinea-pig isolated trachea to the contractile action of adenosine. European Journal of Pharmacology. 214(1). 67–74. 1 indexed citations
15.
Rhaleb, Nour-Eddine, Guy Drapeau, Stéphane Dion, et al.. (1989). Basic Pharmacology of Kinins: Pharmacologic Receptors and other Mechanisms. Advances in experimental medicine and biology. 247A. 399–407. 28 indexed citations
16.
Devillier, P., et al.. (1988). Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. European Respiratory Journal. 1(4). 356–361. 65 indexed citations
17.
Devillier, P., Charles Advenier, Guy Drapeau, J Marsac, & D. Regoli. (1988). Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin‐induced contractions of guinea‐pig isolated trachea. British Journal of Pharmacology. 94(3). 675–684. 126 indexed citations
18.
Meslier, Nicole, J Lacronique, J.F. Dessanges, et al.. (1988). Local Cellular and Humoral Responses to Antigenic and Distilled Water Challenge in Subjects with Allergic Rhinitis. American Review of Respiratory Disease. 137(3). 617–624. 35 indexed citations
19.
Devillier, P., M Renoux, Guy Drapeau, & D. Regoli. (1988). Histamine release from rat peritoneal mast cells by kinin antagonists. European Journal of Pharmacology. 149(1-2). 137–140. 30 indexed citations
20.
Naline, Emmanuel, Charles Advenier, P. Devillier, et al.. (1988). Characterization of neurokinin effects and receptors in human isolated bronchi. Regulatory Peptides. 22(1-2). 133–133. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026